References
- Ishizaka K, Ishizaka T: Biological function of IgE antibodies and mechanisms of reaginic hypersensitivity. Clin Exp Immunol 6;25-42, 1970
- Okudaira H, Sakurai Y, Terada K, Terada E, Ogita T, Miyamoto T: Cyclosporin A-induced suppression of ongoing IgE antibody formation in the mouse. Int Arch Allergy Appl Immunol 79;164-168, 1986 https://doi.org/10.1159/000233965
- Takatsu K, hizaka K: Reaginic antibody formation in the mouse. VI. Suppression of IgE and IgG antibody responses to ovalbumin following the administration of high dose urea-denatured antigen. Cell Immunol 20;276-289, 1975 https://doi.org/10.1016/0008-8749(75)90105-7
- Lee WY, Sehon AH: Abrogation of reaginic antibodies with modified allergens. Nature 267;618-619, 1977 https://doi.org/10.1038/267618a0
- Hayglass KT, Stefura WP: Antigen-specific inhibition of ongoing murine 19E responses. II. Inhibition of 19E responses induced by treatment with glutaraldehyde-modified allergens is paralleled by reciprocal increases in IgG2a synthesis. J Immunol 147;2455-2460, 1991
- Finkelman FD, Katona IM, Mosmann TR, Coffman RL: IFN-gamma regulates the isotypes of Ig secreted during in vivo humoral immune responses. J Immunol 140;1022-1027, 1988
- Souillet G, Rousset F, Vries JE: Alpha-interferon treatment of patient with hyper IgE syndrome. Lancet 1;1384, 1989
- Finkelman FD, Holmes J, Katona IM, Urban JF, Beckmann JrMP, Park LS, Schooley KA, Coffman RL, Mosmann TR, Paul WE: Lymphokine control of in vivo immunoglobulin isotype selection. Annu Rev Immunol 8;303-333, 1990 https://doi.org/10.1146/annurev.iy.08.040190.001511
- Park JS, Choi IH, Lee DG, Han SS, Ha TY, Lee HH, Park YM, Lee HK: Anti-IL-4 monoclonal antibody prevents antibiotics-induced active fatal anaphylaxis. J Immunol 158;5002-6,1997
- Presta LG, Lahr SJ, Shields RL, Porter JP, Gorman CM, Fendly BM, Jardieu PM: Humanization of an antibody directed against IgE. J Immunol 151;2623-2632, 1993
- Fahy JV, Fleming HE, Wong HH, Liu JT, Su JQ, Reimann J, Fick RB Jr, Boushey HA: The effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects. Am J Respir Crit Care Med 155;1828-1834, 1997 https://doi.org/10.1164/ajrccm.155.6.9196082
- Casale TB, Bernstein IL, Busse WW, LaForce CF, Tinkelman DG, Stoltz RR, Dockhorn RJ, Reimann J, Su JQ, Fick RB Jr, Adelman DC: Use of an anti-IgE humanized monoclonal antibody in ragweed-induced allergic rhinitis. J Allergy Clin Immunol 100;110-121, 1997 https://doi.org/10.1016/S0091-6749(97)70202-1
- Saban R, Haak-Frendscho M, Zine M, Ridgway J, Gorman C, Presta LG, Bjorling D, Saban M, Jardieu P: Human FcERI-IgG and humanized anti-IgE monoclonal antibody MaE11 block passive sensitization of human and rhesus monkey lung. J Allergy Clin Immunol 94;836-843, 1994 https://doi.org/10.1016/0091-6749(94)90151-1
- Haak-Frendscho M, Robbins K, Lyon R, Shields R, Hooley J, Schoenhoff M, Jardieu P: Administration of an anti-Igf antibody inhibits CD23 expression and IgE production in vivo. Immunology 82;306-313, 1994
- Haak-Frendscho M, Saban R, Shields RL, Jardieu PM: Anti-immunoglobulin E antibody treatment blocks histamine release and tissue contraction in sensitized mice. Immunology 94;115-121, 1998 https://doi.org/10.1046/j.1365-2567.1998.00478.x
- Owen CE: Anti-immunoglobulin E therapy for asthma. Pulm Pharmacol Ther 15 ;417-424, 2002 https://doi.org/10.1006/pupt.2002.0372
- D'Amato G: Therapy of allergic bronchial asthma with omalizumab - an anti-IgE monoclonal antibody. Expert Opin Biol Ther 3;371-376, 2003 https://doi.org/10.1517/14712598.3.2.371
- Leung DY, Sampson HA, Yunginger JW, Burks AW, Schneider LC, Wortel CH, Davis FM, Hyun JD, Shanahan WR Jr; Avon Longitudinal Study of Parents and Children Study Team: Effect of anti-IgE therapy in patients with peanut allergy. N Engl J Med 348;986-993, 2003 https://doi.org/10.1056/NEJMoa022613
- Weiss ME, Nyhan D, Peng ZK, Horrow JC, Lowenstein E, Hirshman C, Adkinson NF Jr: Association of protamine IgE and IgG antibodies with life-threatening reactions to intravenous protamine. N Engl J Med 320;886-892, 1989 https://doi.org/10.1056/NEJM198904063201402
- Lee HK, Lee HH, Park YM, Park HJ, Lee JH, Ha TY: Anti-IL-4 antibody inhibits antigen specific IgE response bur fails to prevent chicken gamma globulin-induced active systemic anaphylaxis: evidence for the involvement of IgG antibodies. J Korean Med Sci 11;111-117, 1996 https://doi.org/10.3346/jkms.1996.11.2.111
- Atimura A, Nagata M, Watanabe A, Nakamura K, Takeuchi M, Harada M: Production of active and passive anaphylactic shock in the WBB6Fl mouse, a mast cell-deficient strain. Experientia 46;739-742, 1990 https://doi.org/10.1007/BF01939952
- Oettgen HC, Martin TR, Wynshaw-Boris A, Deng C, Drazen JM, Leder P: Active anaphylaxis in IgE-deficient mice. Nature 370;367-370, 1994 https://doi.org/10.1038/370367a0
- Choi IH, Shin YM, Park JS, Lee MS, Han EH, Chai OH, Im SY, Ha TY, Lee HK: IgE-dependent active fatal anaphylaxis in mast cell-deficient mice. J Exp Med 188; 1587-1592, 1998 https://doi.org/10.1084/jem.188.9.1587
- Harlow ED, Lane D: Antibodies a Laboratory Manual. Cold Spring Harbor Laboratory. New York: 1988. p. 628-9
- Ravetch JV, Bolland S: IgG Fc receptors. Annu Rev Immunol 19;275, 2001
- Mechetina LV, Najakshin AM, Alabyev BY, Chikaev NA, Taranin AV: Identification of CD16-2, a novel mouse receptor homologous to CD16/Fc gamma RIII. Immunogenetics 54;463-468, 2002 https://doi.org/10.1007/s00251-002-0486-0
- Amigorena S, Bonnerot C, Choquet D, Fridman WH, Teillaud JL: Fc gamma RII expression in resting and activated B lymphocytes. Eur J Immunol 19;1379-1385, 1989 https://doi.org/10.1002/eji.1830190805
- Amigorena S, Bonnerot C, Drake J, Choquet D, Hunziker W, Guillet JGR, Webster P, Sautes C, Mellman I, Fridman WH: Cytoplasmic domain heterogeneity and functions of IgG Fc receptors in B-Iymphocytes. Science 256;1808-1812, 1992 https://doi.org/10.1126/science.1535455
- Phillips NE, Parker DC: Cross-linking of B lymphocyte Fe gamma receptors and membrane immunoglobulin inhibits anti-immunoglobulin-induced blastogenesis. J Immunol 132;627-632, 1984
- Sinclair NRSC, Chan PL: Regulation of the Immune responses. IV. The role of the Fc-fragment in feedback inhibition by antibody. Adv Exp Med Biol 12;609-615, 1971
- Daeron M, Latour S, Malbec O, Espinosa E, Pina P, Pasmans S, Fridman WH: The same tyrosine-based inhibition motif, in the intracytoplasmic domain of Fc gamma RIIB, regulates negatively BCR-, TCR-, and FcR-dependent cell activation. Immunity 3;635-646, 1995 https://doi.org/10.1016/1074-7613(95)90134-5
- Daeron M, Malbec O, Latour S, Arock M, Fridman WH: Regulation of high-affinity IgE receptor-mediated mast cell activation by murine low-affinity IgG receptors. J Clin Invest 95;577-585, 1995 https://doi.org/10.1172/JCI117701
- Ujike A, Ishikawa Y, Ono M, Yuasa T, Yoshino T, Fukumoto M, Ravetch JV, Takai T: Modulation of immunoglobulin (Ig)E-mediated systemic anaphylaxis by low-affinity Fc receptors for IgG. J Exp Med 189;1573-1579, 1999 https://doi.org/10.1084/jem.189.10.1573
- Muta T, Kurosaki T, Misulovin Z, Sanchez M, Nussenzweig MC, Ravetch JV: A 13-amino-acid motif in the cytoplasmic domain of Fc gamma RIIB modulates B-cell receptor signalling. Nature 369;340, 1994
- Bolland S, Pearse RN, Kurosaki T, Ravetch JV: SHIP modulates immune receptor responses by regulating membrane association of Btk. Immunity 8;509-516, 1998 https://doi.org/10.1016/S1074-7613(00)80555-5
- Scharenberg AM, EI-Hillal O, Fruman DA, Beitz LO, Li Z, Lin S, Gout I, Cantley LC, Rawlings DJ, Kinet JP: Phosphatidylinositol-3, 4, 5-trisphosphate (PtdIns-3, 4, 5P3)/Tec kinase-dependent calcium signaling pathway: A target for SHIP-mediated inhibitory signals. EMBO J 17; 1961-1972, 1998 https://doi.org/10.1093/emboj/17.7.1961
- Van Den Herik-Oudijk IE, Westerdaal NA, Henriquez NV, Capel PJ, Van De Winkel JG: Functional analysis of human Fc gamma RII (CD32) isoforms expressed in B lymphocytes. J Immunol 152;574-585, 1994
- Phillips NE, Parker DC: Cross-linking of B lymphocyte Fc gamma receptors and membrane immunoglobulin inhibits antiimmunoglobulin- induced blastogenesis. J Immunol 132;627-632, 1984
- Fahy JV, Fleming HE, Wong HH, Liu JT, Su JQ, Reimann J, Fick RB Jr, Boushey HA: The effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects. Am J Respir Crit Care Med 155;1828-1834, 1997 https://doi.org/10.1164/ajrccm.155.6.9196082
- Boulet LP, Chapman KR, Cote J, Kalra S, Bhaqat R, Swystun VA, Laviolette M, Cleland LD, Deschesnes F, Su JQ, DeVault A, Fick RB Jr, Cockcroft DW: Inhibitory effects of an anti-IgE antibody E25 on allergen-induced early asthmatic response. Am J Respir Crit Care Med 155;1835-1840, 1997 https://doi.org/10.1164/ajrccm.155.6.9196083
- Milgrom H, Fick RB Jr, Su JQ, Reimann JD, Bush RK, Watrous ML, Metzger WJ: Treatment of allergic asthma with monoclonal anti-lgE antibody. N Engl J Med 341; 1966-1973, 1999 https://doi.org/10.1056/NEJM199912233412603
- Finn A, Gross G, van Bavel J, Lee T, Windom H, Everhard F, Fowler-Taylor A, Liu J, Gupta N: Omalizumab improves asthma-related quality of life in patients with severe allergic asthma. J Allergy Clin Immunol 111;278-284, 2003 https://doi.org/10.1067/mai.2003.54
- Buhl R, Hanf G, Soler M, Bensch G, Wolfe J, Everhard F, Champain K, Fox H, Thirlwell J: The anti-IgE antibody omalizumab improves asthma-related quality of life in patients with allergic asthma. Eur Respir J 20;1088-1094, 2002 https://doi.org/10.1183/09031936.02.00016502
- Lemanske RF, Nayakm A, McAlary M, Everhard F, Fowler-Taylor A, Gupta N: Omalizumab improves asthma-related quality of life in children with allergic asthma. Pediatrics 110;E55, 2002
- Liu J, Lester P, Builder S, Shire SJ: Characterisation of complex formation by humanised anti-IgE monoclonal antibody and monoclonal human IgE. Biochemistry 34;10474-10482, 1995 https://doi.org/10.1021/bi00033a020
- Corne J, Djukanovic R, Thomas L, Warner J, Botta L, Grandordy B, Gygax D, Heusser C, Patalano F, Richardson W, Kilchherr E, Staehelin T, Davis F, Gordon W, Sun L, Liou R, Wang G, Chang TW, Holgate S: The effect of intravenous administration of a chimaeric anti-IgE antibody on serum IgE levels in atopic subjects - efficacy, safety and pharmacokinetics. J Clin Invest 99;879-887, 1997 https://doi.org/10.1172/JCI119252
- Haak-Frendscho M, Robbins K, Lyon R, Shields R, Hooley J, Schoenhoff M, Jardieu P: Administration of an anti-IgE antibody inhibits CD23 expression and IgE production in vivo. Immunology 82;306-313, 1994
- MacGlashan DJr, Xia HZ, Schwartz LB, Gong J: IgE-regulated loss, not IgE-regulated synthesis, controls expression of FcepsilonRI in human basophils. J Leukoc Biol 70;207-218, 2001
- Saini SS, Klion AD, Holland SM, Hamilton RG, Bochner BS, Macglashan DW Jr: The relationship between serum IgE and surface levels of FcepsilonR on human leukocytes in various diseases: correlation of expression with FcepsilonRI on basophils but not on monocytes or eosinophils. J Allergy Clin Immunol 106;514-520, 2000 https://doi.org/10.1067/mai.2000.108431
- MacGlashan DJr, McKenzie-White J, Chichester K, Bochner BS, Davis FM, Schroeder JT, Lichtenstein LM: In vitro regulation of FcepsilonRIaipha expression on human basophils by IgE antibody. Blood 91;1633-1643, 1998
- MacGlashan DWJr, Bochner BS, Adelman DC, Jardieu PM, Toqias A, McKenzie-White J, Sterbinsky SA, Hamilton RG, Lichtenstein LM: Down-regulation of Fc(epsilon)RI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody. J Immunol 158; 1438-1445, 1997
- Chang TW, Shiung YY: Anti-IgE as a mast cell-stabilizing therapeutic agent. J Allergy Clin Immunol 117;1203-1212, 2006 https://doi.org/10.1016/j.jaci.2006.04.005
- Lanier BQ: Unanswered questions and warnings involving anti-immunoglobulin E therapy based on 2-year observation of clinical experience. Allergy Asthma Proc 26;435-439, 2005